Prescription Required
Exemptia 40mg/0.8ml Injection is a biologic medication containing Adalimumab (40mg/0.8ml), a fully human monoclonal antibody. It is designed to target and neutralize tumor necrosis factor-alpha (TNF-α), a pro-inflammatory cytokine implicated in various autoimmune diseases. By inhibiting TNF-α, Exemptia helps reduce inflammation, alleviate symptoms, and prevent disease progression in conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriasis, ulcerative colitis, and Crohn's disease.
There is no direct evidence indicating harmful interactions between Exemptia and alcohol. However, alcohol consumption may exacerbate certain conditions being treated, such as liver disease. It's advisable to consult your healthcare provider regarding alcohol use during treatment.
Exemptia should be used during pregnancy only if clearly needed. Animal studies have shown low or no adverse effects on the developing baby; however, there are limited human studies. Discuss potential risks and benefits with your doctor.
Adalimumab is known to pass into breast milk in small amounts. Limited human data suggest that the drug does not represent any significant risk to the baby. Consult your healthcare provider before using Exemptia while breastfeeding.
Exemptia may cause side effects such as dizziness and vision disturbances, which could affect your ability to drive or operate machinery. If you experience these symptoms, refrain from such activities until you feel better.
There is limited information available on the use of Exemptia in patients with kidney disease. Inform your doctor if you have any renal condition before starting treatment, as dose adjustments may be necessary.
There is limited information available on the use of Exemptia in patients with liver disease. Inform your doctor if you have any hepatic conditions before starting treatment, as dose adjustments may be necessary.
Exemptia 40mg/0.8ml Injection contains Adalimumab, a TNF-α inhibitor. TNF-α is a cytokine that plays a key role in promoting inflammatory responses in autoimmune diseases. By binding specifically to TNF-α, Adalimumab blocks its interaction with cell surface TNF receptors, thereby reducing inflammation and altering the immune response. This mechanism helps alleviate symptoms and prevent disease progression in various inflammatory conditions.
If you miss a dose of Exemptia, follow these steps:
Autoimmune diseases occur when the immune system mistakenly attacks the body's own tissues. Tumor necrosis factor-alpha (TNF-α) is a key inflammatory mediator in many autoimmune conditions. Overactivity of TNF-α leads to excessive inflammation, which damages tissues and causes chronic symptoms such as pain, swelling, and stiffness.
Exemptia 40mg/0.8ml Injection, containing Adalimumab, is a highly effective biologic medication used to treat autoimmune diseases like rheumatoid arthritis, ankylosing spondylitis, psoriasis, Crohn’s disease, and ulcerative colitis. It works by blocking TNF-α, a major inflammatory cytokine, thereby reducing inflammation and preventing disease progression.
While Exemptia offers significant benefits, it must be used cautiously due to potential side effects and interactions with other medications. Proper storage, adherence to dosing schedules, and lifestyle modifications can enhance its effectiveness.
Content Updated on
Thursday, 17 April, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA